SEC Filing Summary: Synaptogenix, Inc. (SNPX)
Business Context and Reporting Period
This Form 8-K Current Report, dated December 6, 2024, details the results of Synaptogenix, Inc.'s Annual Meeting of Stockholders. The registrant is an emerging growth company incorporated in Delaware, with its principal executive offices in New York, New York. The filing addresses corporate governance matters and shareholder approvals rather than periodic financial performance.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on voting outcomes and corporate actions.
Material Changes and Voting Results
On December 6, 2024, stockholders representing approximately 54.03% of outstanding shares (846,988 shares) attended the Annual Meeting. Four proposals were considered and approved:
- Proposal 1 (Election of Directors): Joshua Silverman and William S. Singer were elected to serve until the 2027 annual meeting. Both nominees received significant support, with 369,569 and 367,990 votes "For" respectively.
- Proposal 2 (Board Authorization for Stock Issuance): Shareholders authorized the Board to issue common stock underlying convertible preferred stock and warrants from a September 10, 2024 Securities Purchase Agreement, even if the issuance exceeds 20% of outstanding common stock. The proposal passed with 246,470 votes "For" against 100,776 "Against."
- Proposal 3 (Equity Incentive Plan Amendment): Shareholders approved an amendment to the 2020 Equity Incentive Plan, increasing the authorized share pool from 175,000 to 675,000 shares. The vote was 270,829 "For" versus 194,623 "Against."
- Proposal 4 (Ratification of Auditors): The appointment of Stephano Slack as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified with 690,006 votes "For" and 143,414 "Against."
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors. The primary corporate action noted is the ratification of the independent auditor and the expansion of the equity incentive plan, which may impact future dilution.
Investor Verification Checklist
- Verify the terms of the September 10, 2024 Securities Purchase Agreement referenced in Proposal 2 to understand potential dilution.
- Review the amended 2020 Equity Incentive Plan to assess the impact of the increased share pool (675,000 shares) on future employee compensation and dilution.
- Confirm the engagement letter and scope of work with the newly ratified auditor, Stephano Slack.
- Check subsequent filings (e.g., 10-K or 10-Q) for the actual financial metrics and liquidity status, as they are absent from this 8-K.